Benzinga··Vandana SinghFDA Issues Class I Recall for Tandem Diabetes Mobi Pumps Over Insulin Delivery Risk
FDA classifies Class I recall for Tandem Diabetes' Mobi insulin pumps due to false motor failure detection risking insulin delivery interruption.
TNDMFDA recallmedical device